Zobrazeno 1 - 10
of 555
pro vyhledávání: ''
Publikováno v:
OncoTargets and therapy
Epidermal growth factor receptor (EGFR) fusions are rare genomic events in non-small-cell lung cancer (NSCLC). With advances in detection technology, some uncommon genomic mutation events, including EGFR fusions, have been detected. There are no stan
Publikováno v:
OncoTargets and therapy
Early T‐cell precursor acute lymphoblastic leukemia (ETP-ALL) is an aggressive and extremely fatal subtype of T-cell acute lymphoblastic leukemia (T-ALL), characterized by the similar transcriptional and immunophenotypic profiles to those of early
Publikováno v:
OncoTargets and therapy
Fangyuan Cao,1,2 Mumu Shi,1 Bo Yu,1 Xiangrong Cheng,3 Xin Li,4 Xinshan Jia5 1Department of Pathology, Science and Education Department of the Fifth People’s Hospital of Qinghai, Xining, Qinhai, 810000, People’s Republic of China; 2Department of P
Publikováno v:
OncoTargets and therapy
Synchronous occurrences of gastric cancer positive for human epidermal growth factor receptor 2 (HER2+) and bladder cancer are rarely encountered in clinical practice. When and how to effectively treat both tumors, without compounding adverse effects
Autor:
Siqing Fu, Vivek Subbiah, Wendy Xiong, Shreyaskumar Patel, Sarina Anne Piha-Paul, Filip Janku, Aung Naing, Daniel D. Karp, Funda Meric-Bernstam, Nizar M. Tannir, Li Xu, Binoj Nair, Najat C. Daw, Ralph Zinner, Rosa Mostorino, Ecaterina Elena Dumbrava, David S. Hong
Publikováno v:
OncoTargets and therapy
Sarina A Piha-Paul,1 Ecaterina E Dumbrava,1 Binoj C Nair,1 Wendy Xiong,1 Li Xu,1 Rosa Mostorino,1 Vivek Subbiah,1 Nizar Tannir,2 Siqing Fu,1 Aung Naing,1 Filip Janku,1 Daniel D Karp,1 Shreyaskumar Patel,3 Najat C Daw,4 David Hong,1 Funda Meric-Bernst
Autor:
Margarita L. Tyndyk, Anastasia A Dorofeeva, Elena I. Fedoros, Vladimir N. Anisimov, Mikhail Maydin, Stepan Kruglov, Andrey V. Panchenko, Vladislav K. Osetnik, Ekaterina A. Gubareva, G. S. Kireeva
Publikováno v:
OncoTargets and therapy
Galina Kireeva,1 Ekaterina Gubareva,1 Mikhail Maydin,1 Vladislav Osetnik,2 Stepan Kruglov,1 Andrey Panchenko,1 Anastasia Dorofeeva,1 Margarita Tyndyk,1 Elena Fedoros,1 Vladimir Anisimov1 1Department of Carcinogenesis and Aging, N.N. Petrov National M
Publikováno v:
OncoTargets and therapy
Non-Hodgkin lymphoma can disseminate to the central nervous system at initiation of treatment for systemic lymphoma or spread during the relapse of systematic lymphoma with CNS involvement, which is defined as secondary central nervous system lymphom
Publikováno v:
OncoTargets and therapy
Approximately 70% of breast cancer (BC) cases are hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) BC. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have acted as star drugs for reversing endocrine t
Publikováno v:
OncoTargets and therapy
Dehui Fu, Chao Li, Yongwang Huang Department of Ear-Nose-Throat (ENT), The Second Hospital of Tianjin Medical University, Tianjin, 300211, People’s Republic of ChinaCorrespondence: Yongwang HuangDepartment of Ear-Nose-Throat, The Second Hospital of
Publikováno v:
OncoTargets and therapy
Epstein–Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) complicated with angioimmunoblastic T-cell lymphoma (AITL) is extremely rare and typically shows an aggressive clinical course and unsatisfactory prognosis. Here, we describe t